HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial copper depletion suppresses triple-negative breast cancer in mice.

Abstract
Depletion of mitochondrial copper, which shifts metabolism from respiration to glycolysis and reduces energy production, is known to be effective against cancer types that depend on oxidative phosphorylation. However, existing copper chelators are too toxic or ineffective for cancer treatment. Here we develop a safe, mitochondria-targeted, copper-depleting nanoparticle (CDN) and test it against triple-negative breast cancer (TNBC). We show that CDNs decrease oxygen consumption and oxidative phosphorylation, cause a metabolic switch to glycolysis and reduce ATP production in TNBC cells. This energy deficiency, together with compromised mitochondrial membrane potential and elevated oxidative stress, results in apoptosis. CDNs should be less toxic than existing copper chelators because they favorably deprive copper in the mitochondria in cancer cells instead of systemic depletion. Indeed, we demonstrate low toxicity of CDNs in healthy mice. In three mouse models of TNBC, CDN administration inhibits tumor growth and substantially improves survival. The efficacy and safety of CDNs suggest the potential clinical relevance of this approach.
AuthorsLiyang Cui, Arvin M Gouw, Edward L LaGory, Shenghao Guo, Nabeel Attarwala, Yao Tang, Ji Qi, Yun-Sheng Chen, Zhou Gao, Kerriann M Casey, Arkadiy A Bazhin, Min Chen, Leeann Hu, Jinghang Xie, Mingxi Fang, Cissy Zhang, Qihua Zhu, Zhiyuan Wang, Amato J Giaccia, Sanjiv Sam Gambhir, Weiping Zhu, Dean W Felsher, Mark D Pegram, Elena A Goun, Anne Le, Jianghong Rao
JournalNature biotechnology (Nat Biotechnol) Vol. 39 Issue 3 Pg. 357-367 (03 2021) ISSN: 1546-1696 [Electronic] United States
PMID33077961 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Chelating Agents
  • Copper
Topics
  • Animals
  • Cell Death
  • Cell Line, Tumor
  • Chelating Agents (metabolism)
  • Copper (metabolism)
  • Disease Models, Animal
  • Female
  • Humans
  • Mice
  • Mitochondria (metabolism)
  • Oxidative Phosphorylation
  • Triple Negative Breast Neoplasms (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: